NON-INVASIVE TESTS AS SURROGATES FOR FIBROSIS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC)

被引:0
|
作者
Salazar, Jesus Enrique Romero [1 ]
Socorro, Ana Lucia Romero [1 ]
Phan, Quynh-An [2 ]
Mohamed, Sadde A. [2 ]
Buddha, Mrinalini [2 ]
Egwim, Chukwuma [3 ]
Ankoma-Sey, Victor [2 ]
机构
[1] Trinitas Reg Med Ctr, Houston, TX USA
[2] Liver Associates Texas PA, Houston, TX USA
[3] Houston Methodist Hosp, Weill Cornell Med Coll, JC Walter Jr Transplant Ctr, Sherrie & Alan Conover Ctr Liver Dis & Transplant, Houston, TX USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1284
引用
收藏
页码:771A / 771A
页数:1
相关论文
共 50 条
  • [1] Characteristics of Significant Fibrosis by Transient Elastography and Evaluation of Non-Invasive Fibrosis Tests in Patients With Primary Biliary Cholangitis
    Jacob, Ahlin
    Alhankawi, Dhuha
    Niknam, Negar
    Shah, Prasun
    Park, James
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S21 - S22
  • [2] DIFFERENTIAL OUTCOMES BETWEEN URSODIOL RESPONDERS VS NON-RESPONDERS REGARDING NON-INVASIVE PARAMETERS OF FIBROSIS IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS (PBC).
    Socorro, Ana Lucia Romero
    Salazar, Jesus Enrique Romero
    Sanchez, Miriam Mercedes
    Buddha, Mrinalini
    Avila, Daniel
    Egwim, Chukwuma
    Ankoma-Sey, Victor
    [J]. HEPATOLOGY, 2021, 74 : 757A - 758A
  • [3] Non-Invasive Assessment of Liver Fibrosis Progression and Prognosis in Primary Biliary Cholangitis
    Poupon, Raoul
    [J]. DIGESTIVE DISEASES, 2015, 33 : 115 - 117
  • [4] Non-invasive assessment of esophageal and fundic varices in patients with primary biliary cholangitis
    Zhang, Yuan
    Huang, Chunyang
    Meng, Fankun
    Hu, Xing
    Huang, Xiaojie
    Chang, Jing
    Han, Xue
    Zhang, Tieying
    Han, Jing
    Ge, Huiyu
    [J]. EUROPEAN RADIOLOGY, 2024,
  • [5] Non-Invasive Prediction of High-Risk Varices in Patients with Primary Biliary Cholangitis and Primary Sclerosing Cholangitis
    Moctezuma-Velazquez, Carlos
    Saffioti, Francesca
    Tasayco-Huaman, Stephanie
    Casu, Stefania
    Mason, Andrew
    Roccarina, Davide
    Vargas, Victor
    Nilsson, Jan-Erick
    Tsochatzis, Emmanuel
    Augustin, Salvador
    Montano-Loza, Aldo J.
    Berzigotti, Annalisa
    Thorburn, Douglas
    Genesca, Joan
    Abraldes, Juan Gonzalez
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (03): : 446 - 452
  • [6] NON-INVASIVE PREDICTORS OF ADVANCED DISEASE IN PRIMARY BILIARY CIRRHOSIS (PBC)
    Noureddin, Mazen
    Woolridge, Daniel
    Zhao, Xiongce
    Noureddin, Nabil
    DeMino, Mary
    Liang, T. Jake
    Kleiner, David E.
    Heller, Theo
    Hoofnagle, Jay H.
    [J]. HEPATOLOGY, 2011, 54 : 1213A - 1213A
  • [7] Non-invasive evaluation of progression to primary biliary cholangitis in patients with positive antimitochondrial antibodies
    Diaz Gonzalez, Alvaro
    Alonso-Pena, Marta
    Monte, Maria
    Perello, Christie
    Iruzubieta, Paula
    Cobreros, Marina
    Irure, Juan
    Lopez-Hoyos, Marcos
    Calleja Panero, Jose Luis
    Marin, Jose
    Crespo, Javier
    [J]. JOURNAL OF HEPATOLOGY, 2023, 78 : S390 - S391
  • [8] Characterization of Primary Biliary Cholangitis (PBC) in Canadian Patients
    Yoshida, Eric M.
    Bailey, Robert James
    Elkhashab, Magdy
    Grbic, Dusanka
    Hilzenrat, Nir
    Kim, Euiseok
    Minuk, Gerald Y.
    O'Brien, Meaghan B.
    Peltekian, Kevork M.
    Puglia, Marco A.
    Ramji, Ainoor
    Swain, Mark Gordon
    Tam, Edward V.
    Tsien, Cynthia
    Vincent, Catherine
    Popovic, Vlad
    Twiseiton, Jamie
    Yap, Belinda
    [J]. HEPATOLOGY, 2018, 68 : 1089A - 1090A
  • [9] Can simple Non-Invasive Fibrosis Models Determine Prognostic Indicators (Fibrosis and Treatment Response) of Primary Biliary Cholangitis?
    Sayar, Suleyman
    Gokcen, Pinar
    Aykut, Huseyin
    Adali, Gupse
    Doganay, Hamdi Levent
    Ozdil, Kamil
    [J]. MEDICAL BULLETIN OF SISLI ETFAL HOSPITAL, 2021, 55 (03): : 412 - 418
  • [10] Systematic review: non-invasive prognostic tests for primary sclerosing cholangitis
    Mazhar, Areej
    Russo, Mark W.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (07) : 774 - 783